Trial Profile
A study to evaluate whether the tocilizumab enhances regulatory t-cell activation and proliferation in giant cell arteritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Giant cell arteritis
- Focus Biomarker; Pharmacodynamics
- 08 Feb 2016 New trial record